US20190000767A1 - Tamper resistant dosage forms - Google Patents

Tamper resistant dosage forms Download PDF

Info

Publication number
US20190000767A1
US20190000767A1 US16/115,024 US201816115024A US2019000767A1 US 20190000767 A1 US20190000767 A1 US 20190000767A1 US 201816115024 A US201816115024 A US 201816115024A US 2019000767 A1 US2019000767 A1 US 2019000767A1
Authority
US
United States
Prior art keywords
mg
extended release
tablet
temperature
dosage form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US16/115,024
Inventor
William H. McKenna
Richard O. Mannion
Edward P. O'Donnell
Haiyong H. Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Pharma LP
Purdue Pharmaceuticals LP
Original Assignee
Purdue Pharma LP
Purdue Pharmaceuticals LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US84024406P priority Critical
Priority to US11/844,872 priority patent/US8894987B2/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38754532&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20190000767(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to US13/803,132 priority patent/US20140030327A1/en
Priority to US14/515,924 priority patent/US9084816B2/en
Priority to US14/729,593 priority patent/US9486412B2/en
Priority to US15/263,932 priority patent/US9775812B2/en
Priority to US15/597,885 priority patent/US20170246116A1/en
Priority to US15/885,074 priority patent/US20180369150A1/en
Application filed by Purdue Pharma LP, Purdue Pharmaceuticals LP filed Critical Purdue Pharma LP
Priority to US16/115,024 priority patent/US20190000767A1/en
Publication of US20190000767A1 publication Critical patent/US20190000767A1/en
Application status is Abandoned legal-status Critical

Links